Latest Forum Topics /
UGHealthcare
Last:0.084
-0.002
|
 Post Reply
|
|
Gloves and more
|
|||||
|
Inferno
Senior |
11-May-2021 09:39
|
||||
|
x 0
x 0 Alert Admin |
Expected good results.. may not translate to any buyer confidence through. | ||||
| Useful To Me Not Useful To Me | |||||
|
Joelton
Supreme |
11-May-2021 09:08
|
||||
|
x 0
x 0 Alert Admin |
UG Healthcare posts S$34.3m Q3 net profit
IN a business update, glovemaker UG Healthcare posted a net profit of S$34.3 million for the third quarter ended March 31, 2021, almost 57 times its net profit in the previous year.
The group produced and sold a higher volume of gloves and had relatively stable average selling prices of both nitrile and natural latex gloves in key markets during the quarter.
As a result, revenue more than doubled to S$93.5 million from S$38.6 million, even surpassing the S$91.8 million recorded for the nine-month period ended March 31 the year before.
Gross profit jumped to S$58.6 million from S$7.5 million, translating to a 43.2 percentage-point increase in gross margin to 62.7 per cent. The group had higher margins for both its upstream manufacturing and downstream distribution businesses.
UG Healthcare noted that it has recorded four consecutive quarters of earnings growth from Q4 FY20. It said it continued to operate at optimum efficiency in Q3 FY21, with its upstream manufacturing capacity of 2.9 billion pieces of gloves per annum. Around 85 per cent of gloves were sold under its Unigloves brand through its own downstream distribution companies.
" We are, however, mindful of the impending challenges ahead such as rising costs and the surge in production capacities, which could lead to the average selling prices adjusting correspondingly to the increase in the global supply of gloves as competition warms up at the upstream manufacturing level," said Lee Jun Yih, executive director and finance director.
The group has commissioned the production capacity of 500 million pieces of gloves per annum since April 2021, bringing its total annual production capacity to 3.4 billion pieces of gloves.
The Covid-19 situation in Malaysia has caused slight delay to the construction of the new factory for the additional capacity of 1.2 billion pieces of gloves per annum. This means the company will gradually commission the production lines from Q3 of calendar year 2021, bringing its total annual production capacity to 4.6 billion pieces of gloves in the financial year ending June 30, 2022.
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Sibehboeng
Master |
11-May-2021 01:11
|
||||
|
x 0
x 0 Alert Admin |
If that level were true then got release news of profit like no release coz 2 weeks back the price was already at 7ish before it dived...
|
||||
| Useful To Me Not Useful To Me | |||||
|
MondayBlue
Member |
10-May-2021 20:59
|
||||
|
x 0
x 0 Alert Admin |
Great! so as shareholders, we should be celebrating and toasting our well run company - right? How far are we expecting the counter to move tomorrow? |
||||
| Useful To Me Not Useful To Me | |||||
|
jimmysum
Member |
10-May-2021 20:00
|
||||
|
x 0
x 0 Alert Admin |
UG Healthcare posted a net profit of S$34.3 million for the third quarter ended March 31, 2021, almost 57 times its net profit in the previous year. | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
jimmysum
Member |
10-May-2021 19:59
|
||||
|
x 0
x 0 Alert Admin |
https://www.businesstimes.com.sg/companies-markets/ug-healthcare-posts-s343m-q3-net-profit | ||||
| Useful To Me Not Useful To Me | |||||
|
Hellvish
Senior |
10-May-2021 18:08
|
||||
|
x 0
x 0 Alert Admin |
https://links.sgx.com/FileOpen/UG%20Healthcare_Voluntary%20Business%20Update_10%20May%202021.ashx?App=Announcement& FileID=665636 | ||||
| Useful To Me Not Useful To Me | |||||
|
Shifu8888
Supreme |
10-May-2021 17:52
|
||||
|
x 0
x 0 Alert Admin |
If protracted linear growth into next quarter net cash about 60-70.
The realistic dividend will be 4-5 cents but the waiting time has risk of cos.
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Shifu8888
Supreme |
10-May-2021 17:45
|
||||
|
x 0
x 0 Alert Admin |
EPS (TTM): 3.25 times based on closing price
This should move back to above 70 tmr. Caution when 70 breaks. 75 is always a huge resistance. |
||||
| Useful To Me Not Useful To Me | |||||
|
Richardlai
Master |
10-May-2021 17:25
|
||||
|
x 0
x 0 Alert Admin |
Yep, new release etc | ||||
| Useful To Me Not Useful To Me | |||||
|
Sibehboeng
Master |
10-May-2021 16:31
|
||||
|
x 0
x 0 Alert Admin |
Today supposed to have update announcement? | ||||
| Useful To Me Not Useful To Me | |||||
|
FreedomAngelz
Veteran |
10-May-2021 16:23
|
||||
|
x 0
x 0 Alert Admin |
If UG cash balance can increased to $70m and above...i see it as a positive sign to keep for good dividend payout in next quarter result
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Richardlai
Master |
10-May-2021 15:40
|
||||
|
x 0
x 0 Alert Admin |
Generally I am expecting some good news from this counter ..... if not, everyone would have dumped it by now . Just my guess Good luck guys ! |
||||
| Useful To Me Not Useful To Me | |||||
|
tonyja
Elite |
08-May-2021 12:43
|
||||
|
x 0
x 0 Alert Admin |
WHO gives emergency approval to Sinopharm, first Chinese COVID-19 vaccine07 May 2021 11:34PM
Asia
A general practitioner opens a packet containing vials of China' s Sinopharm COVID-19 vaccine on Mar 25, 2021. (Photo: AP/MTI/Attila Balazs) (Updated: 08 May 2021 12:11AM)
BookmarkGENEVA: The World Health Organization announced on Friday (May 7) it had approved a COVID-19 vaccine from China' s state-owned drugmaker Sinopharm for emergency use. The vaccine, one of two main Chinese shots that collectively have already been given to hundreds of millions of people in China and abroad, becomes the first COVID-19 shot developed by a non-Western country to win the WHO' s backing. READ: Sinovac COVID-19 vaccine effective but some data lacking: WHO expertsIt is also the first time the WHO has given emergency use approval to any Chinese vaccine for any infectious disease. A WHO emergency listing is a signal to national regulators on a product' s safety and efficacy, and would allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries. " This afternoon, WHO gave emergency use listing to Sinopharm Beijing' s COVID-19 vaccine, making it the sixth vaccine to receive WHO validation for safety, efficacy and quality," the UN health agency' s director-general Tedros Adhanom Ghebreyesus told a news conference. Tedros also said that a separate expert panel has recommended two doses of Sinopharm vaccine for those aged 18 and above. The WHO has previously given emergency approval to COVID-19 vaccines developed by Pfizer-BioNTech, AstraZeneca, Johnson & Johnson, and, last week, Moderna. READ: On vaccinating the globe, Blinken warns: ' We have to speed this up'The decision to approve Sinopharm' s vaccine was taken by WHO' s technical advisory group, which began meeting on Apr 26 to review the latest clinical data as well as Sinopharm' s manufacturing practices. A separate group of WHO experts, the Strategic Advisory Group of Experts (SAGE), voiced concern this week over data provided by Sinopharm on the risk of serious side-effects in some patients, but was confident in the vaccine' s ability to prevent disease, according to a document reviewed by Reuters. SAGE found an efficacy of 78.1 per cent after two doses in multi-country Phase III clinical trials, according to the document. The vaccine' s developer, Beijing Biological Products Institute, a unit of Sinopharm subsidiary China National Biotec Group, had announced an efficacy of 79.34 per cent. READ: EU regulator reviews reports of rare nerve disorder after AstraZeneca shotThe WHO has said it could reach a decision on China' s other main COVID-19 vaccine, made by Sinovac Biotech, as soon as next week. The technical experts reviewed it on Wednesday. China has deployed around 65 million doses of the Sinopharm vaccine and more than 200 million doses of the Sinovac shot. Both have been exported to many countries, particularly in Latin America, Asia and Africa, many of which have had difficulty securing supplies of vaccines developed in the West. |
||||
| Useful To Me Not Useful To Me | |||||
|
Richardlai
Master |
07-May-2021 09:45
|
||||
|
x 0
x 0 Alert Admin |
Noticed traders can move the prices up and down like yoyo ! Hope shortist have covered back ... if not they will be caught with their pants down ! | ||||
| Useful To Me Not Useful To Me | |||||
|
PhillipTan
Supreme |
07-May-2021 09:45
|
||||
|
x 0
x 0 Alert Admin |
Oh, I see But I think they will need to buy at quite low prices to be able to sell at current prices for a profit Cutting losses on a dip seems a bit senseless when company is doing well in a profitable market Anyway, it' s moving up again hahaha
|
||||
| Useful To Me Not Useful To Me | |||||
|
Inferno
Senior |
07-May-2021 09:22
|
||||
|
x 0
x 0 Alert Admin |
Nothing wrong. I am just stating my view on why holding power is so weak on this counter. Not all are investors though.. some more speculators. |
||||
| Useful To Me Not Useful To Me | |||||
|
PhillipTan
Supreme |
07-May-2021 09:19
|
||||
|
x 0
x 0 Alert Admin |
Nothing wrong in trading and making a quick buck I suppose all investors are out to make money right?
|
||||
| Useful To Me Not Useful To Me | |||||
|
Inferno
Senior |
07-May-2021 09:17
|
||||
|
x 0
x 0 Alert Admin |
Surprise it continue dropping today. That shows people holding this stock does not believe in its fundamental.. just want to trade and make a few quick bucks. | ||||
| Useful To Me Not Useful To Me | |||||
|
PhillipTan
Supreme |
07-May-2021 09:07
|
||||
|
x 0
x 0 Alert Admin |
Wow, dropping so much lower than I last sold What happened? 
|
||||
| Useful To Me Not Useful To Me | |||||